questionsmedicales.fr
Phénomènes physiologiques respiratoires et circulatoires
Phénomènes physiologiques respiratoires
Capacité pulmonaire totale
Capacité vitale
Capacité vitale : Questions médicales fréquentes
Termes MeSH sélectionnés :
Multifactorial Inheritance
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Capacité vitale : Questions médicales les plus fréquentes",
"headline": "Capacité vitale : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Capacité vitale : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-22",
"dateModified": "2025-04-16",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Capacité vitale"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Capacité pulmonaire totale",
"url": "https://questionsmedicales.fr/mesh/D014109",
"about": {
"@type": "MedicalCondition",
"name": "Capacité pulmonaire totale",
"code": {
"@type": "MedicalCode",
"code": "D014109",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G09.772.850"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Volume de réserve expiratoire",
"alternateName": "Expiratory Reserve Volume",
"url": "https://questionsmedicales.fr/mesh/D005105",
"about": {
"@type": "MedicalCondition",
"name": "Volume de réserve expiratoire",
"code": {
"@type": "MedicalCode",
"code": "D005105",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G09.772.850.970.360"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Capacité inspiratoire",
"alternateName": "Inspiratory Capacity",
"url": "https://questionsmedicales.fr/mesh/D007320",
"about": {
"@type": "MedicalCondition",
"name": "Capacité inspiratoire",
"code": {
"@type": "MedicalCode",
"code": "D007320",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G09.772.850.970.500"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Volume de réserve inspiratoire",
"alternateName": "Inspiratory Reserve Volume",
"url": "https://questionsmedicales.fr/mesh/D007321",
"about": {
"@type": "MedicalCondition",
"name": "Volume de réserve inspiratoire",
"code": {
"@type": "MedicalCode",
"code": "D007321",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G09.772.850.970.500.375"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Volume courant",
"alternateName": "Tidal Volume",
"url": "https://questionsmedicales.fr/mesh/D013990",
"about": {
"@type": "MedicalCondition",
"name": "Volume courant",
"code": {
"@type": "MedicalCode",
"code": "D013990",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G09.772.850.970.500.700"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Capacité vitale",
"alternateName": "Vital Capacity",
"code": {
"@type": "MedicalCode",
"code": "D014797",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Toby M Maher",
"url": "https://questionsmedicales.fr/author/Toby%20M%20Maher",
"affiliation": {
"@type": "Organization",
"name": "Keck School of Medicine, University of Southern California, Los Angeles, California, USA."
}
},
{
"@type": "Person",
"name": "Hyun Lee",
"url": "https://questionsmedicales.fr/author/Hyun%20Lee",
"affiliation": {
"@type": "Organization",
"name": "Division of Pulmonary Medicine and Allergy, Department of Internal Medicine, Hanyang University College of Medicine, Seoul, South Korea."
}
},
{
"@type": "Person",
"name": "Hye Yun Park",
"url": "https://questionsmedicales.fr/author/Hye%20Yun%20Park",
"affiliation": {
"@type": "Organization",
"name": "Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea."
}
},
{
"@type": "Person",
"name": "Masato Kono",
"url": "https://questionsmedicales.fr/author/Masato%20Kono",
"affiliation": {
"@type": "Organization",
"name": "Department of Respiratory Medicine, Seirei Hamamatsu General Hospital, Hamamatsu, Japan. Electronic address: masato.k@sis.seirei.or.jp."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Voretigene neparvovec for inherited retinal dystrophy due to RPE65 mutations: a scoping review of eligibility and treatment challenges from clinical trials to real practice.",
"datePublished": "2024-04-16",
"url": "https://questionsmedicales.fr/article/38627549",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41433-024-03065-6"
}
},
{
"@type": "ScholarlyArticle",
"name": "Discovering SNP-disease relationships in genome-wide SNP data using an improved harmony search based on SNP locus and genetic inheritance patterns.",
"datePublished": "2023-10-13",
"url": "https://questionsmedicales.fr/article/37831690",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pone.0292266"
}
},
{
"@type": "ScholarlyArticle",
"name": "Current Assistive Devices Usage and Recommendations for a Future Artificial Vision Prosthesis among Patients with Severe Visual Impairment Due to Inherited Retinal Diseases.",
"datePublished": "2023-08-14",
"url": "https://questionsmedicales.fr/article/37629325",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/jcm12165283"
}
},
{
"@type": "ScholarlyArticle",
"name": "Change in Cerebrospinal Fluid Tau Microtubule Binding Region Detects Symptom Onset, Cognitive Decline, Tangles, and Atrophy in Dominantly Inherited Alzheimer's Disease.",
"datePublished": "2023-03-16",
"url": "https://questionsmedicales.fr/article/36843330",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/ana.26620"
}
},
{
"@type": "ScholarlyArticle",
"name": "Post-procedural bleeding rate and haemostatic treatment use for dental procedures before and after the implementation of a standardized protocol for people with inherited bleeding disorders.",
"datePublished": "2022-06-25",
"url": "https://questionsmedicales.fr/article/35751905",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/hae.14609"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Phénomènes physiologiques respiratoires et circulatoires",
"item": "https://questionsmedicales.fr/mesh/D002943"
},
{
"@type": "ListItem",
"position": 3,
"name": "Phénomènes physiologiques respiratoires",
"item": "https://questionsmedicales.fr/mesh/D012143"
},
{
"@type": "ListItem",
"position": 4,
"name": "Capacité pulmonaire totale",
"item": "https://questionsmedicales.fr/mesh/D014109"
},
{
"@type": "ListItem",
"position": 5,
"name": "Capacité vitale",
"item": "https://questionsmedicales.fr/mesh/D014797"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Capacité vitale - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Capacité vitale",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-16",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Capacité vitale",
"description": "Comment évaluer la capacité vitale ?\nQuels tests complètent l'évaluation ?\nQuels sont les critères normaux de capacité vitale ?\nQuand suspecter une capacité vitale réduite ?\nQuels signes indiquent un problème pulmonaire ?",
"url": "https://questionsmedicales.fr/mesh/D014797?mesh_terms=Multifactorial+Inheritance&page=200#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Capacité vitale",
"description": "Quels symptômes sont liés à une capacité vitale faible ?\nLa toux est-elle un symptôme associé ?\nComment la fatigue se manifeste-t-elle ?\nY a-t-il des signes d'alerte ?\nLes symptômes varient-ils selon l'âge ?",
"url": "https://questionsmedicales.fr/mesh/D014797?mesh_terms=Multifactorial+Inheritance&page=200#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Capacité vitale",
"description": "Comment prévenir la réduction de la capacité vitale ?\nLes vaccinations sont-elles importantes ?\nQuel rôle joue l'exercice physique ?\nFaut-il éviter certaines expositions ?\nL'hydratation est-elle importante ?",
"url": "https://questionsmedicales.fr/mesh/D014797?mesh_terms=Multifactorial+Inheritance&page=200#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Capacité vitale",
"description": "Quels traitements améliorent la capacité vitale ?\nLa physiothérapie est-elle utile ?\nLes médicaments peuvent-ils aider ?\nQuand envisager une intervention chirurgicale ?\nLes traitements varient-ils selon la cause ?",
"url": "https://questionsmedicales.fr/mesh/D014797?mesh_terms=Multifactorial+Inheritance&page=200#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Capacité vitale",
"description": "Quelles complications peuvent survenir ?\nLa capacité vitale faible augmente-t-elle les risques ?\nLes maladies cardiaques sont-elles liées ?\nComment les infections affectent-elles la capacité vitale ?\nY a-t-il des effets à long terme ?",
"url": "https://questionsmedicales.fr/mesh/D014797?mesh_terms=Multifactorial+Inheritance&page=200#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Capacité vitale",
"description": "Quels sont les principaux facteurs de risque ?\nL'âge influence-t-il la capacité vitale ?\nLes maladies chroniques sont-elles un facteur ?\nLe sexe joue-t-il un rôle ?\nL'environnement de travail est-il un facteur ?",
"url": "https://questionsmedicales.fr/mesh/D014797?mesh_terms=Multifactorial+Inheritance&page=200#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment évaluer la capacité vitale ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "La capacité vitale est mesurée par spirométrie, un test de la fonction pulmonaire."
}
},
{
"@type": "Question",
"name": "Quels tests complètent l'évaluation ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests comme la pléthysmographie et les gaz du sang peuvent être utilisés."
}
},
{
"@type": "Question",
"name": "Quels sont les critères normaux de capacité vitale ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les valeurs normales varient selon l'âge, le sexe et la taille, généralement entre 3 et 6 L."
}
},
{
"@type": "Question",
"name": "Quand suspecter une capacité vitale réduite ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une capacité vitale réduite est suspectée en cas de dyspnée ou d'antécédents de maladies pulmonaires."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent un problème pulmonaire ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme la toux persistante ou la fatigue peuvent indiquer une capacité vitale altérée."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés à une capacité vitale faible ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent essoufflement, fatigue, et sensation d'oppression thoracique."
}
},
{
"@type": "Question",
"name": "La toux est-elle un symptôme associé ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une toux persistante peut accompagner une capacité vitale diminuée."
}
},
{
"@type": "Question",
"name": "Comment la fatigue se manifeste-t-elle ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "La fatigue peut se manifester par une diminution de l'énergie et des difficultés à l'effort."
}
},
{
"@type": "Question",
"name": "Y a-t-il des signes d'alerte ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme des douleurs thoraciques ou une cyanose nécessitent une attention médicale immédiate."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon l'âge ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent être plus prononcés chez les personnes âgées en raison de la dégradation pulmonaire."
}
},
{
"@type": "Question",
"name": "Comment prévenir la réduction de la capacité vitale ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter le tabagisme, pratiquer une activité physique régulière et avoir une alimentation équilibrée."
}
},
{
"@type": "Question",
"name": "Les vaccinations sont-elles importantes ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les vaccins contre la grippe et le pneumocoque aident à prévenir les infections respiratoires."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'exercice physique ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'exercice régulier améliore la fonction pulmonaire et la capacité vitale."
}
},
{
"@type": "Question",
"name": "Faut-il éviter certaines expositions ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, éviter les polluants et les allergènes peut aider à préserver la santé pulmonaire."
}
},
{
"@type": "Question",
"name": "L'hydratation est-elle importante ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une bonne hydratation aide à maintenir la santé des voies respiratoires."
}
},
{
"@type": "Question",
"name": "Quels traitements améliorent la capacité vitale ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la réhabilitation pulmonaire, les bronchodilatateurs et les corticostéroïdes."
}
},
{
"@type": "Question",
"name": "La physiothérapie est-elle utile ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la physiothérapie respiratoire aide à améliorer la capacité vitale et la fonction pulmonaire."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils aider ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments comme les bronchodilatateurs peuvent aider à ouvrir les voies respiratoires."
}
},
{
"@type": "Question",
"name": "Quand envisager une intervention chirurgicale ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une chirurgie peut être envisagée en cas de maladies pulmonaires graves, comme la BPCO."
}
},
{
"@type": "Question",
"name": "Les traitements varient-ils selon la cause ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le traitement dépend de la cause sous-jacente de la réduction de la capacité vitale."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent l'insuffisance respiratoire et des infections pulmonaires."
}
},
{
"@type": "Question",
"name": "La capacité vitale faible augmente-t-elle les risques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une capacité vitale faible augmente le risque de complications respiratoires graves."
}
},
{
"@type": "Question",
"name": "Les maladies cardiaques sont-elles liées ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une capacité vitale réduite peut être associée à un risque accru de maladies cardiaques."
}
},
{
"@type": "Question",
"name": "Comment les infections affectent-elles la capacité vitale ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les infections pulmonaires peuvent réduire la capacité vitale en provoquant une inflammation."
}
},
{
"@type": "Question",
"name": "Y a-t-il des effets à long terme ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une capacité vitale réduite peut entraîner des effets à long terme sur la santé respiratoire."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les principaux facteurs incluent le tabagisme, l'exposition à des polluants et des antécédents familiaux."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il la capacité vitale ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la capacité vitale diminue généralement avec l'âge en raison de la dégradation pulmonaire."
}
},
{
"@type": "Question",
"name": "Les maladies chroniques sont-elles un facteur ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies comme l'asthme ou la BPCO augmentent le risque de capacité vitale réduite."
}
},
{
"@type": "Question",
"name": "Le sexe joue-t-il un rôle ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les hommes ont généralement une capacité vitale plus élevée que les femmes en moyenne."
}
},
{
"@type": "Question",
"name": "L'environnement de travail est-il un facteur ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, travailler dans des environnements pollués ou dangereux peut affecter la capacité vitale."
}
}
]
}
]
}
Biallelic mutations in the RPE65 gene affect nearly 8% of Leber Congenital Amaurosis and 2% of Retinitis Pigmentosa cases. Voretigene neparvovec (VN) is the first gene therapy approach approved for th...
Advances in high-throughput sequencing technologies have made it possible to access millions of measurements from thousands of people. Single nucleotide polymorphisms (SNPs), the most common type of m...
Patients with inherited retinal diseases (IRDs) utilize various adaptive techniques and devices designed to assist them with activities of daily living (ADLs). The purpose of this study was to assess ...
Identifying cerebrospinal fluid measures of the microtubule binding region of tau (MTBR-tau) species that reflect tau aggregation could provide fluid biomarkers that track Alzheimer's disease related ...
Cross-sectional and longitudinal CSF from 229 DIAD mutation carriers and 130 mutation non-carriers had sequential characterization of N-terminal/mid-domain phosphorylated tau (p-tau) followed by MTBR-...
CSF MTBR-tau species located within the putative "border" region and one species corresponding to the "core" region of aggregates in neurofibrillary tangles (NFTs) increased during the presymptomatic ...
Changes in CSF soluble MTBR-tau species preceded the onset of dementia, tau tangle increase, and atrophy in DIAD. The ratio of 4R-specific MTBR-tau (border) to the NFT (core) MTBR-tau species correspo...
Persons with inherited bleeding disorders are at a substantial risk of bleeding following dental procedures....
To compare the outcomes and use of haemostatic treatment pre- and post-implementation of a standardized protocol for dental procedures at a Hemophilia Treatment Centre....
We conducted a retrospective cohort study of outpatient and inpatient dental procedures and maxillofacial surgeries sustained by people with bleeding disorders treated at a comprehensive Hemophilia Tr...
Overall, 137 dental procedures in 95 patients (median age: 29 years; 78% males; 74% haemophilia, 14% von Willebrand disease, 12% other disorders) were included. Seventeen procedural bleedings were rep...
The use of a standardized protocol increased the use of tranexamic acid, with a nonstatistically significant reduction in procedural bleeding rate....
RYR1 variants are the most common genetic cause of congenital myopathies, and typically cause central core disease (CCD) and/or malignant hyperthermia (MH). Here, we generated iPSC lines from two pati...
Accumulating evidence points out that sperm carry epigenetic instructions to embryo in the form of retained histones marks and RNA cargo that can transmit metabolic and behavioral traits to offspring....
Hereditary actin-related protein 2/3 complex subunit 1B deficiency is characterized clinically by ear, skin, and lung infections, bleeding, eczema, food allergy, asthma, skin vasculitis, colitis, arth...
We aimed to describe the clinical, laboratory, and genetic features of six patients from four Mexican families....
We performed exome sequencing in patients of four families with suspected actinopathy, collected their data from medical records, and reviewed the literature for reports of other patients with actin-r...
Six patients from four families were included. All had recurrent infections, mainly bacterial pneumonia, and cellulitis. A total of 67% had eczema whereas 50% had food allergies, failure to thrive, he...
Actin-related protein 2/3 complex subunit 1B deficiency has a variable and heterogeneous clinical spectrum, expanded by these cases to include keloid scars and Epstein-Barr virus chronic hepatitis. A ...
The efficacy of low molecular weight heparin (LMWH) is well-established in patients with obstetric antiphospholipid syndrome (O-APS). Their role in women with unexplained recurrent pregnancy loss (U-R...